Thioredoxin and aging: What have we learned from the survival studies?
Open Access
- 29 September 2020
- journal article
- Published by Ant Publishing in Aging Pathobiology and Therapeutics
- Vol. 2 (3), 126-133
- https://doi.org/10.31491/apt.2020.09.028
Abstract
Thioredoxin and aging: What have we learned from the survival studies?Keywords
This publication has 36 references indexed in Scilit:
- The complexity of NF-κB signaling in inflammation and cancerMolecular Cancer, 2013
- Thioredoxin 1 Overexpression Extends Mainly the Earlier Part of Life Span in MiceThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2011
- Is the oxidative stress theory of aging dead?Biochimica et Biophysica Acta (BBA) - General Subjects, 2009
- Attenuation of Angiotensin II–Induced Vascular Dysfunction and Hypertension by Overexpression of Thioredoxin 2Hypertension, 2009
- Thioredoxin 2 haploinsufficiency in mice results in impaired mitochondrial function and increased oxidative stressFree Radical Biology & Medicine, 2008
- Endothelial-Specific Expression of Mitochondrial Thioredoxin Improves Endothelial Cell Function and Reduces Atherosclerotic LesionsThe American Journal of Pathology, 2007
- Thioredoxin-2 affects lifespan and oxidative stress in DrosophilaHereditas, 2007
- Lifespan decrease in a Caenorhabditis elegans mutant lacking TRX‐1, a thioredoxin expressed in ASJ sensory neuronsFEBS Letters, 2005
- Targeting HIF-1 for cancer therapyNature Reviews Cancer, 2003
- The Absence of Mitochondrial Thioredoxin 2 Causes Massive Apoptosis, Exencephaly, and Early Embryonic Lethality in Homozygous MiceMolecular and Cellular Biology, 2003